Atara Biotherapeutics, Inc.

Q3 2021 vs. Q4 2021 13F Holders

Period
Q3 2021
Q4 2021
Num holders
143
144
Total reported value, excl. options
$1.61 B
$1.51 B
Total shares, excl. options
89,699,088
95,532,252
Manager Q3 2021
Shares
Q4 2021
Shares
Diff Chg %